Le Lézard
Classified in: Health
Subjects: BFA, TRI

SinuSonic Clinical Trial Data Shows Safety and Efficacy for a Novel, Nonpharmacologic Device for Nasal Congestion Relief


COLUMBIA, S.C., Dec. 2, 2019 /PRNewswire/ -- Healthy Humming, LLC is pleased to announce positive topline data from a prospective outcomes study, which assessed the safety and efficacy of the SinuSonic, a nasal congestion treatment device that combines nasal acoustic vibration with oscillating expiratory pressure.

While chronic nasal congestion impacts millions of Americans each year1, currently available treatments, including pharmacologic and surgical options, demonstrate variable efficacy and side effects. The SinuSonic is the only patents-pending treatment option available today that combines the delivery of acoustic vibrations with the application of oscillating expiratory pressure to relieve nasal congestion. The latest independent study, performed at the Medical University of South Carolina, investigated both the safety and efficacy of SinuSonic for the treatment of nasal congestion.

"We were quite surprised at the effectiveness of the SinuSonic device for patients with nasal congestion.  Our data, which will be presented formally early next year, showed significant improvement across all primary and secondary study endpoints after use of SinuSonic, including both objective and patient-reported outcomes," said principal author, Zachary M. Soler, M.D., M.Sc. of the Medical University of South Carolina.

Topline outcomes from the study included:

"We're encouraged by the preliminary topline results from this phase I/II clinical trial," said David Lewis, co-founder of Healthy Humming. "These results should give confidence to patients and physicians that SinuSonic is supported by scientific evidence demonstrating that patients not only feel better but have real changes in nasal airflow after using our device.  We're excited for the full study results to be presented and published next year. In the meantime, we look forward to spreading the word that SinuSonic is a great option for millions of Americans suffering from nasal congestion."

SinuSonic is available for retail purchase online on Amazon or through SinuSonic.com.

About SinuSonic

Founded in Columbia, South Carolina, and born through the research and partnerships of Richard K. Bogan, M.D. and David J. Lewis, SinuSonic is the first-ever nasal congestion relief device to use acoustic vibrations to help provide nasal congestion relief. Users simply hold the device's nasal mask to their nose and press the device's trigger button to activate a gentle acoustic vibration. By breathing in and out through the device, users experience light resistance and an oscillating 'flutter' pressure as they exhale. The simple combination of sound and pressure has been shown to relieve nasal congestion.

For instructional videos, visit sinusonic.com. To request samples, demo meetings, or more information, click here or contact the media contact listed below.

Disclaimers
Though Dr. Soler is currently employed by the Medical University of South Carolina (MUSC), neither the Medical University of South Carolina, nor any affiliated organizations shall be responsible for information provided herein under any theory of liability or indemnity.

1Stewart M, Ferguson B, Fromer L. Epidemiology and burden of nasal congestion. Int J Gen Med 2010;3:37-45

2 Peak Nasal Inspiratory Flow is an objective measure that measures nasal airflow during inspiration and supplements standard patient reported outcome measures.

 

 

SOURCE SinuSonic


These press releases may also interest you

at 11:04
Addressing the issue of employee wellness in healthcare, the American Association for Physician Leadership (AAPL) has published a new book, Working Happy! How to Survive Burnout and Find Your Work/Life Synergy in the Healthcare Industry. Author...

at 11:00
TDIndustries, a leading mechanical construction and facilities services firm, proudly announces that its Vice President of Environmental, Health and Safety Jamie Dabbs, CSP, ASP, CRIS, was named Construction Safety Professional of the Year by...

at 11:00
Nicklaus Children's Hospital this month attained Magnet recognition by the American Nurses Credentialing Center's Magnet Recognition Program® for the fifth consecutive term. Nicklaus Children's is one of only five children's hospitals in the nation...

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...



News published on and distributed by: